ISSN: 1522-8002

Journal Home

Neoplasia Q2 Unclaimed

Neoplasia Press United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Neoplasia is a journal indexed in SJR in Cancer Research with an H index of 140. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2250 €. The scope of the journal is focused on cancer, tumors, oncology research, medicine. It has an SJR impact factor of 1,451 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,451.

Neoplasia focuses its scope in these topics and keywords: gene, breast, cell, cancer, gastric, promotes, hybridizationfibroblastic, human, intrahepatic, lapatinibresistant, ...

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q2)

Price

2250 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,451

SJR Impact factor

140

H Index

78

Total Docs (Last Year)

284

Total Docs (3 years)

4322

Total Refs

1466

Total Cites (3 years)

282

Citable Docs (3 years)

4.53

Cites/Doc (2 years)

55.41

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Frontiers in Oncology Q2
International Journal of Oncology Q2
Cancer Epidemiology Q2
Virus Research Q2
Familial Cancer Q2

Compare this journals

Aims and Scope

Best articles by citations

Tumor-Targeted Hyaluronan Nanoliposomes Increase the Antitumor Activity of Liposomal Doxorubicin in Syngeneic and Human Xenograft Mouse Tumor Models

Profile - American Cancer Society

Microtubule-Targeting Drugs Induce Bcl-2 Phosphorylation and Association with Pin1

The Cure for Lymphoma Foundation

Inhibition of Tumor Growth, Angiogenesis, and Microcirculation by the Novel Flk-1 Inhibitor SU5416 as Assessed by Intravital Multi-fluorescence Videomicroscopy

The National Brain Tumor Foundation: Giving Help, Giving Hope

Concern Foundation: Funding Cancer Research Worldwide

American Brain Tumor Association: Sharing Knowledge, Sharing Hope

Aberrant Methylation of the Maspin Promoter Is an Early Event in Human Breast Cancer

National Childhood Cancer Foundation

The International Myeloma Foundation

Art Of The Brain: UCLA Neuro-Oncology Program

SHOW MORE ARTICLES

The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate

National Foundation for Cancer Research

Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells in Human Renal Cell Carcinoma Is a Primary Target for Therapy by Tyrosine Kinase Inhibitors

The G&P Foundation for Cancer Research

Kidney Cancer Association

The Association for International Cancer Research

Neoplasia profile: American Institute for Cancer Research

Neoplasia: Where We Have Been and Where We Are Going

The V Foundation for Cancer Research

Implications of Mapping the Human Telomerase Gene (hTERT) as the Most Distal Gene on Chromosome 5p

Editorial